Fresh Biopharmas Join the Race to Cutting-Edge Treatments and Testing

Several companies launched with Series A financing rounds Thursday. Read on for details.

Tectonic Therapeutics. Based in Boston, the company raised $80 million in Series A financing co-led by Vida Ventures, TA Springer, and Polaris Partners, with participation from EcoR1 Capital.